Tue, Sep 30, 2014, 6:12 AM EDT - U.S. Markets open in 3 hrs 18 mins

Recent

% | $
Quotes you view appear here for quick access.

Lpath Inc. Message Board

john_j_315 166 posts  |  Last Activity: 15 hours ago Member since: Apr 5, 2010
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Where is Management????

    by birdshooter_6 Jul 15, 2014 11:11 AM
    john_j_315 john_j_315 Jul 15, 2014 1:52 PM Flag

    If Don were to buy the company outright, why would he care about those 500,000 shares? He would be picking up 16,500,000 cheaper. Regardless, no one would do anything like that. Way too obvious. There are ways to do all of this stuff legally. The question is do we have something here that works and are we going to make money or are we being led into a disaster. Who buys what and for how much is going to be what it will be if anything here works.

    Sentiment: Hold

  • Reply to

    did i ever mention

    by thebigfella1234 Jul 15, 2014 10:35 AM
    john_j_315 john_j_315 Jul 15, 2014 11:12 AM Flag

    Yes and it is definitely not the free money the fed is handing out that is causing any of this "frothiness" in valuations. Just dumb investors.

    Sentiment: Hold

  • Reply to

    did i ever mention

    by thebigfella1234 Jul 15, 2014 10:35 AM
    john_j_315 john_j_315 Jul 15, 2014 10:41 AM Flag

    Perpetuating the disaster that was Bernanke. I hope once Obama is out there will be some changes.

    Sentiment: Hold

  • john_j_315 john_j_315 Jul 15, 2014 10:00 AM Flag

    I can't figure out the trading here. Someone(s) is/are hitting both the bid and the ask with relatively large buys/sells. I could see one or the other but both I don't get.

    Sentiment: Hold

  • Reply to

    Stroke Rounds: An MS Drug for ICH?

    by tvillekirbys Jul 9, 2014 10:20 PM
    john_j_315 john_j_315 Jul 14, 2014 5:34 PM Flag

    The insiders here have not nor will they likely ever buy stock in the open market. Definitely would not hold your breath on that one. As far as the company goes, I purposely left the name out. It is just an example and not really important since it is gone but I am sure you could figure it out if you did a little research.

    Sentiment: Hold

  • Reply to

    Stroke Rounds: An MS Drug for ICH?

    by tvillekirbys Jul 9, 2014 10:20 PM
    john_j_315 john_j_315 Jul 14, 2014 2:54 PM Flag

    Can your reliable source give you any reason why they are allowing the stock to be pummeled while keeping all the latest updates basically out of the mainstream? That is the real question of the day.

    Sentiment: Hold

  • Reply to

    Stroke Rounds: An MS Drug for ICH?

    by tvillekirbys Jul 9, 2014 10:20 PM
    john_j_315 john_j_315 Jul 14, 2014 2:51 PM Flag

    Understood. Was just curious because while I don't think it is meaningful from an insider trading point of view, it definitely sounds like "inside" information.

    I would hope they would want to advance each one individually long before they started down any road like that though unless it was on someone else's tab.

    Sentiment: Hold

  • Reply to

    Stroke Rounds: An MS Drug for ICH?

    by tvillekirbys Jul 9, 2014 10:20 PM
    john_j_315 john_j_315 Jul 14, 2014 2:13 PM Flag

    That's a fairly specific rumor. Do you have a source at the company or something?

    Sentiment: Hold

  • Reply to

    This stock is half of what it was 1 year ago

    by opto7825 Jul 12, 2014 5:45 PM
    john_j_315 john_j_315 Jul 14, 2014 9:55 AM Flag

    If Pfizer is interested in anything here, my opinion is they will buy everything and sell off what they don't want. I just don't see any benefit to executing or selling their option. In fact, I can't imagine that was ever their intention. I mean why would you? Besides, who's to say it isn't Pfizer we are talking about in this scenario anyway?

    I think they just put the option on the market to see what they could get. Since there was no serious interest, they are sitting on it for now. If they really don't want any of it, they will likely try to sell the option with good results or let it expire with mediocre or bad. If they want anything, my best guess is they will make an offer. But, the company is under no obligation to accept it so there is still an out. Even if there is a brewing war between Pfizer and Management and Pfizer executes the iSONEP or ASONEP option or both, the company is suddenly worth a lot of money anyway so it is a win win for LPath. Either they get it cheap or they get a big payday and everyone goes away with $$$.

    I have no crystal ball or inside information here. This is just my gut based on what I have seen in the past and my experience working on deals. Here's hoping...

    Sentiment: Hold

  • Reply to

    This stock is half of what it was 1 year ago

    by opto7825 Jul 12, 2014 5:45 PM
    john_j_315 john_j_315 Jul 14, 2014 9:01 AM Flag

    By the way, the chair of the other company was 77.

    Sentiment: Hold

  • Reply to

    This stock is half of what it was 1 year ago

    by opto7825 Jul 12, 2014 5:45 PM
    john_j_315 john_j_315 Jul 14, 2014 8:52 AM Flag

    I don't know about Swortwood himself but the connection/entanglement with WSIC is very interesting to me. And I guess I would be surprised if he is displeased. If he was I doubt Scott would be where he is and getting paid what he is in light of his performance. That fact right there has me scratching my head. Why do you continue to reward a guy so well when on the face of it (at least publicly) appears he is performing so poorly? Guys like that always have their bases covered anyway. I bet money there is a plan unfolding here and kudos to the guy who figures it out first.

    With respect to buying the company, that could be anyone really. I don't know that it necessarily has to be an insider directly. Could be a connection we know nothing about. Maybe something through WSIC. Like I said before, the best way to play this is to put yourself in the shoes of these guys and play dirty. In the end if we make a little money, regardless of how much was taken via what we are seeing happening, the argument will be we made a little money while sitting and watching so why are we complaining?

    As a side note, there was a shareholder lawsuit filed against the board and management of the other company and it was quickly dismissed behind the secrecy door. To the lawyers and judge new to the case, everything looked fine. Struggling company, lagging price and an angel comes in a couple of bucks over the current stagnant price and saves the shareholders. Now the new owner is reporting timely stellar results in all of the indications as expected. Go figure.

    Sentiment: Hold

  • Reply to

    This stock is half of what it was 1 year ago

    by opto7825 Jul 12, 2014 5:45 PM
    john_j_315 john_j_315 Jul 13, 2014 6:58 PM Flag

    It would be "schitzo" and if anyone is a Lacy here, I think you are much closer to the front of the line than I am there movie star.

    Sentiment: Hold

  • Reply to

    This stock is half of what it was 1 year ago

    by opto7825 Jul 12, 2014 5:45 PM
    john_j_315 john_j_315 Jul 13, 2014 9:19 AM Flag

    This has always been a high risk investment and the outcome is binary. The only outlier is how much additional unnecessary dilution are we going to have to endure before we have some sort of actionable results - good or bad.

    Scott does not know what he is doing, he doesn't care or he is sitting on his hands. None of those equal solid performance in a stock. Surprise surprise. And the low float/low price here pretty much eliminates the possibility of any institutional interest. It is exactly what you would expect to see in our situation.

    People sell when the risk outweighs the reward for them or for cash flow reasons. There is no conspiracy in the pricing in that regard. People are getting out and there are no significant buyers except when the price drops and you get the bottom feeders like us who are holding onto the hope and averaging down.

    The bigger issue we have now (dilution aside) is when an illiquid/ill managed stock gets beat down like this, it is very difficult to recover - even with good news as we have already seen. I held another stock almost identical to LPTN and super solid phase II results barely moved the price. Why? Too many false starts and delays. Basically no one was listening anymore - Just like here. I would not be slightly surprised if we end up with dead air with great results.

    In that other stock, I am of the opinion it was purposely done because in the end, the company was bought by another company owned by the chairman of the board for a fraction of what it was worth and no one saw it coming.. The sad part is, it was optically palatable because everything was justified - even a second Phase II study after the first one easily met it's endpoints. Not saying it is the same here but this sure smells the same to me. Almost by the numbers. Like I always say, when stuff doesn't make sense, there is usually a reason.

    I still think there is money to be made here but I just don't see it being a lottery win.

    Sentiment: Hold

  • Reply to

    Something scary..

    by slumdawg2011 Jul 11, 2014 10:26 AM
    john_j_315 john_j_315 Jul 11, 2014 5:10 PM Flag

    I said if there are any specific restrictions on insiders (management) they are in the bylaws and are on a company by company basis. The restrictions on insiders besides that are based on general rules associated with inside information that apply to everyone including you and me. You can find this on the SEC website.

    Sentiment: Hold

  • john_j_315 by john_j_315 Jul 11, 2014 1:58 PM Flag

    Just wanted to say thanks again Scott.

    Sentiment: Hold

  • Reply to

    Something scary..

    by slumdawg2011 Jul 11, 2014 10:26 AM
    john_j_315 john_j_315 Jul 11, 2014 10:59 AM Flag

    Someone is selling plain and simple. Who knows who or why but the fact remains that they know as much as we do. The decision is straight forward - in or out. Apparently someone decided out.

    Sentiment: Hold

  • john_j_315 john_j_315 Jul 11, 2014 6:34 AM Flag

    That is correct James. No one here including some self proclaimed "experts" know whether any of this works or not. Everyone was saying the same about iSONEP many years ago after phase I results and now through the magic of television the topic has switched to ASONEP. It's like deja vu. Who knows whether the topic five year from now will be Lpathomab with no news on iSONEP or ASONEP.

    You guys need to hammer it into your brains that you can read all the stories you want and reference all the other companies with similar developments you want but at the end of the day it is the trial outcomes HERE that matter. And no, I don't take anything the master spin doctor Scott says literally. I find it amazing how someone who has you guys so stirred up can't move the stock price if his life depended on it. Actually I take that back. I know exactly why he can't get the price up. Lack of credibility. Oh, that's right, I already said that didn't I?

    By the way, a "spin" is not the same as an outright "lie" but neither is a good thing in investing.

    Sentiment: Hold

  • john_j_315 john_j_315 Jul 10, 2014 5:14 PM Flag

    You are right about the CEO but you know as much as the rest of us about the indications which after five years and millions of dollars is unfortunately still just about zero.

    Sentiment: Hold

  • Reply to

    Nivolumab vs Asonep

    by jamess.reed Jul 7, 2014 1:08 PM
    john_j_315 john_j_315 Jul 10, 2014 10:57 AM Flag

    Down 31% to about $0.52 from the negative value added reverse split. Congratulations to all on yet another new low! What an outstanding board and management team we have!

  • Reply to

    Nivolumab vs Asonep

    by jamess.reed Jul 7, 2014 1:08 PM
    john_j_315 john_j_315 Jul 7, 2014 3:57 PM Flag

    The way an ROFR works is if LPTN gets an acceptable offer from someone for ASONEP, Pfizer has the option to force LPTN to sell it to them under the same terms instead of the competitor and I don't believe the option limits LPTN from getting offers even now. They just have to run them by Pfizer first to see if Pfizer wants to get in or pass. In that light, there would be no reason for an early opt in unless someone made an offer. Regardless, as I said before, I think an opt in is unlikely. Never say never but a buyout would make the most sense if they wanted ASONEP..

    Sentiment: Hold

LPTN
3.51+0.12(+3.54%)Sep 29 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.